Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Targeted modification of the cationic anticancer peptide HPRP-A1 with iRGD to improve specificity, penetration, and tumor-tissue accumulation
Immunotherapies Cancer immunotherapy targeting p53 is also a prospective therapeutic approach aimed at improving the ability of the immune system to recognize and kill tumor cells expressing abnormal p53
In lean tissue, IGF keeps insulin from moving glucose across cell layers
Structural research has also explored how cagrilintide interacts with calcitonin and amylin receptors, adding receptor binding detail that helps translate amylin analogue into a clearer mechanistic picture
Supports immune health
Related guides: Buy Peptides UK | Research Peptides UK | Certificates of Analysis | Are Peptides Legal in the UK
US$ 23.34
US$ 21.37
US$ 23.32
US$ 29.50
